The official blog of the Lung Institute.

This Week in Lung Disease: Man Dies from “Bagpipe Lung”

26 Aug 2016
| Under Lifestyle | Posted by
This Week in Lung Disease


For those having trouble finding interesting news affecting those with lung disease, have no fear. Each week, the Lung Institute searches the internet to find the latest lung disease news, so you can focus on your family and health.

Man Dies from “Bagpipe Lung”

A case study published Monday gave an old lung disease a new name – “bagpipe lung.”

Doctors in England looked at a case involving a man who died of hypersensitivity pneumonitis, a condition similar to pneumonia. This disease is triggered by the immune system’s response to an inhaled allergen. The man, 61, was an avid bagpipe player and doctors decided to examine his bag. During the examination, doctors found several kinds of fungi.

Until recently, bagpipes were made from leather, which needed to be “seasoned” to stay in working order. This seasoning process had an antiseptic and antifungal effect. Newer bagpipes, made from a synthetic material, do not require seasoning which can contribute to the growth of the fungi.

For more information, read the full story on CNN.

Ramen Surpasses Tobacco as Most Popular Prison Currency

In prison movies, it’s common to see prisoners trading cigarettes for items and services, but that may be a thing in the past.

Ramen noodles have passed tobacco as the most popular prison currency, according to a new study. The study, conducted by the University of Arizona, found this spike was due to the decline in quality and quantity of food served in prison as a cost cutting measure. This has in-turn made Ramen a valuable commodity.

For more information, check out The Guardian.

Air Quality Control Report Looks to Lower Sick Days, Save Lives

The American Thoracic Society has published their recommendations on air quality standards as a way to save lives and cut down on sick days. The group, consisting of scientists from New York University and the Marron Institute of Urban Management, said if their standards were implemented, there would be 9,320 fewer deaths and 19 million fewer sick days taken. These recommendations would be stricter than those issued by the Environmental Protection Agency.

For more information, go to Fox News.

Quitting Smoking May Lead to Making More Friends

According to a new study, smokers fear that quitting may lead to losing friends, but the opposite may actually be true. The study, conducted by the Center for Tobacco Research and Intervention at the University of Wisconsin-Madison, said that those who quit gain nonsmoking friends. As the popularity of smoking is at its lowest ever, the pool of potential friends is much greater than the pool of people who smoke.

For more information, go to Fox News.

Keep checking in with us for the latest lung disease news. If you or someone you know has a chronic lung disease, remember there is hope. At the Lung Institute, we specialize in cellular therapys for those with lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. For more information about the Lung Institute or cellular therapy, please contact one of our patient coordinators by calling 888-745-6697 today.

*For more information, go to www.LungInstitute.com/Results.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.